Stevens R, Simons G, Brand T, Hettema W, Corradini L, Pollenter S. Phase 1 study of the safety and tolerability of single ascending doses of the novel oral CCR2 antagonist CNTX-6970 in healthy volunteers [abstract]. Pain Med. 2018;19(4). doi.org/10.1093/pm/pny044
Published by Oxford University Press on behalf of the American Academy of Pain Medicine. Please visit: https://academic.oup.com/painmedicine/article/19/4/818/4954176